Eye Care (Pharmacies) - Australia & Oceania

  • Australia & Oceania
  • Revenue in the Eye Care market is projected to reach US$147.60m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.93%, resulting in a market volume of US$159.30m by 2028.
  • In global comparison, most revenue will be generated in Japan (US$904.40m in 2024).
  • In relation to total population figures, per person revenues of US$3.40 are generated in 2024.

Key regions: United Kingdom, Australia, India, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care (Pharmacies) market in Australia & Oceania is experiencing steady growth and development, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Eye Care (Pharmacies) market in Australia & Oceania are shifting towards a greater emphasis on preventive eye care and overall eye health. Customers are becoming more aware of the importance of regular eye check-ups and are seeking products and services that cater to their specific eye care needs. This includes a demand for a wide range of contact lenses, prescription glasses, and sunglasses that offer both style and functionality. Additionally, customers are increasingly looking for natural and organic eye care products that are free from harmful chemicals and additives. Trends in the Eye Care (Pharmacies) market in Australia & Oceania are also influencing its development. One significant trend is the growing popularity of online eyewear retailers, which offer convenience and a wide selection of products at competitive prices. This trend is particularly prominent in Australia, where online eyewear retailers have gained a strong foothold in the market. Another trend is the increasing adoption of advanced technologies in eye care, such as telemedicine and digital retinal imaging, which allow for remote diagnosis and monitoring of eye conditions. Local special circumstances in Australia & Oceania further contribute to the development of the Eye Care (Pharmacies) market. Australia, for example, has a high prevalence of eye conditions such as myopia and age-related macular degeneration, which drives the demand for eye care products and services. Additionally, the aging population in Australia & Oceania is creating a larger customer base for eye care, as older individuals are more likely to require vision correction and treatment for age-related eye conditions. Underlying macroeconomic factors also play a role in the development of the Eye Care (Pharmacies) market in Australia & Oceania. Economic growth and rising disposable incomes in the region contribute to increased consumer spending on eye care products and services. Additionally, government initiatives and policies aimed at promoting eye health and providing access to affordable eye care services further support the growth of the market. In conclusion, the Eye Care (Pharmacies) market in Australia & Oceania is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As customers place a greater emphasis on preventive eye care and overall eye health, the market is witnessing a shift towards a wider range of products and services. The adoption of advanced technologies and the rise of online eyewear retailers are also shaping the market. Local factors such as the high prevalence of eye conditions and the aging population contribute to the growth of the market, while favorable macroeconomic conditions support increased consumer spending on eye care.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)